Given several DNA repair mechanisms are deficient in several NE-associated premature ageing syndromes, it can be suggested that silencing of these NE proteins may provide effective monotherapies or in combination with other DNA repair targeted cancer therapies. The gene discussed is ELANE; the disease is cancer.